#CTRX-101
LightNews LightNews
newsen.bsky.social
Revolutionary Anti-Fentanyl Therapy Showcases Promise in Overdose Reversal#United_States#Seattle#CounterX_Therapeutics#CTRX-101#opioid_overdose
Revolutionary Anti-Fentanyl Therapy Showcases Promise in Overdose Reversal
CounterX Therapeutics has unveiled a groundbreaking therapy, CTRX-101, that demonstrates potential in reversing life-threatening fentanyl overdoses, a significant development in tackling opioid abuse.
third-news.com
October 29, 2025 at 12:52 PM
l2plabs.bsky.social
CounterX Therapeutics to Present at the 88th Annual College on Problems of Drug Dependence (CPDD) Scientific Meeting
Company leadership to highlight advances in the development of CTRX-101, a once-monthly monoclonal antibody for the prevention of fentanyl overdose and the company's pipeline SEATTLE, June 3, 2026 /PRNewswire/ -- CounterX Therapeutics, a biotechnology company focused on developing novel...
dlvr.it
June 3, 2026 at 12:50 PM
l2plabs.bsky.social
CounterX Therapeutics Announces Publication Demonstrating CTRX-101, an Anti-Fentanyl Monoclonal Antibody Therapy, Reverses Fentanyl-Induced Overdose in Preclinical Model
SEATTLE, Oct. 29, 2025 /PRNewswire/ -- CounterX Therapeutics, Inc., a biotechnology company focused on developing novel antibody therapeutics and vaccines to address opioid overdose and dependence, today announced the publication of its latest peer-reviewed preclinical study in The...
dlvr.it
October 29, 2025 at 12:40 PM